Review article · 2025 · Open access
Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies
RSC Medicinal Chemistry, 16(5), 1879–1890 · Published 1 January 2025 · DOI 10.1039/d4md00777h
In brief
“Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies” is a 2025 review article by Shanshan Li and 5 co-authors, published in RSC Medicinal Chemistry. OpenAlex counts 33 citations as of 15 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access: the full text is free to read at PubMed Central.
- Citations
- 33
- Most cited in
- 2026 (24)
- Field-weighted impact
- 2.48
- References
- 110
- Authors
- 6
Abstract
Oxazole, a five-membered aromatic heterocycle featuring a nitrogen and an oxygen atom separated by a carbon atom, and its isomer isoxazole, with directly attached oxygen and nitrogen atoms, have been pivotal in medicinal chemistry. Over the past few decades, the U.S. Food and Drug Administration (FDA) has approved more than 20 drugs containing these nuclei for various clinical conditions, including Tafamidis and Oxaprozin. Due to their unique physicochemical properties, these drugs often exhibit superior pharmacokinetic profiles and pharmacological effects compared to those with similar heterocycles. This review provides a comprehensive overview of all FDA-approved drugs containing oxazole and isoxazole nuclei, focusing on their pharmacological activities and structure-activity relationships.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Li, S., Mei, Y., Jiang, L., Yang, X., Zeng, W., & Du, Y. (2025). Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies. RSC Medicinal Chemistry, 16(5), 1879–1890. https://doi.org/10.1039/d4md00777h
MLA 9
Li, Shanshan, et al. “Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies.” RSC Medicinal Chemistry, vol. 16, no. 5, 2025, pp. 1879–1890. https://doi.org/10.1039/d4md00777h.
Chicago
Li, Shanshan, Yiou Mei, Luchen Jiang, Xueyan Yang, Wei Zeng, and Yunfei Du. 2025. “Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies.” RSC Medicinal Chemistry 16 (5): 1879–1890. https://doi.org/10.1039/d4md00777h.
Harvard
Li, S. et al. (2025) ‘Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies’, RSC Medicinal Chemistry, 16(5), pp. 1879–1890. doi:10.1039/d4md00777h.
IEEE
S. Li, Y. Mei, L. Jiang, X. Yang, W. Zeng, and Y. Du, “Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies,” RSC Medicinal Chemistry, vol. 16, no. 5, pp. 1879–1890, 2025, doi: 10.1039/d4md00777h.
BibTeX
@article{li2025oxazole,
title = {{Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies}},
author = {Li, Shanshan and Mei, Yiou and Jiang, Luchen and Yang, Xueyan and Zeng, Wei and Du, Yunfei},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {5},
pages = {1879--1890},
doi = {10.1039/d4md00777h},
url = {https://doi.org/10.1039/d4md00777h}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- oxazoles
- isoxazoles
- five-membered aromatic heterocycles
- FDA-approved drugs
- structure-activity relationship
- pharmacological activity
- pharmacokinetics
- tafamidis
Work with this paper
Most-cited papers in Chemistry
- CRC Handbook of Chemistry and PhysicsW.M. Haynes · CRC Press eBooks · 2014 · 58,210 citations
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Harry Towbin, Th. Staehelin, J Gordon · Proceedings of the National Academy of Sciences · 1979 · 53,242 citations
- Crystal structure refinement with SHELXLGeorge M. Sheldrick · Acta Crystallographica Section C Structural Chemistry · 2014 · 45,305 citations
- Comparison of simple potential functions for simulating liquid waterWilliam L. Jorgensen, Jayaraman Chandrasekhar, Jeffry D. Madura and 2 more · The Journal of Chemical Physics · 1983 · 41,735 citations
- Equation of State Calculations by Fast Computing MachinesN. Metropolis, Arianna W. Rosenbluth, M. N. Rosenbluth and 2 more · The Journal of Chemical Physics · 1953 · 38,111 citations
Questions about this paper
How do I cite this paper in APA style?
Li, S., Mei, Y., Jiang, L., Yang, X., Zeng, W., & Du, Y. (2025). Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies. RSC Medicinal Chemistry, 16(5), 1879–1890. https://doi.org/10.1039/d4md00777h
How many times has this paper been cited?
33 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at PubMed Central.
Who wrote this paper?
Shanshan Li, Yiou Mei, Luchen Jiang, Xueyan Yang, Wei Zeng, Yunfei Du.
What is the DOI of this paper?
10.1039/d4md00777h. The permanent link is https://doi.org/10.1039/d4md00777h.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.